CC BY
0Molecular Cell
Article
Complex Inhibitory Effects of Nitric Oxide on Autophagy
Sovan Sarkar,110 Viktor I. Korolchuk,19 Maurizio Renna,19 Sara Imarisio,129 Angeleen Fleming,1'3 9 Andrea Williams,1 Moises Garcia-Arencibia,1 Claudia Rose,1 Shouqing Luo,1 Benjamin R. Underwood,1 Guido Kroemer,4,5,6,7 8 Cahir J. O'Kane,2 and David C. Rubinsztein1*
1 Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK 2Department of Genetics
3Department of Physiology, Development and Neuroscience University of Cambridge, Downing Street, Cambridge CB2 3EG, UK 4INSERM, U848, Villejuif F-94805, France
5Metabolomics Platform, Institut Gustave Roussy, 94805 Villejuif, France 6Centre de Recherche des Cordeliers, 75006 Paris, France
7Pole de Biologie, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France 8Universite Paris Descartes, Paris 5, Paris, France 9These authors contributed equally to this work
10Present address: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA 'Correspondence: dcr1000@cam.ac.uk DOI 10.1016/j.molcel.2011.04.029
SUMMARY
Autophagy, a major degradation process for long-lived and aggregate-prone proteins, affects various human processes, such as development, immunity, cancer, and neurodegeneration. Several autophagy regulators have been identified in recent years. Here we show that nitric oxide (NO), a potent cellular messenger, inhibits autophagosome synthesis via a number of mechanisms. NO impairs autophagy by inhibiting the activity of S-nitrosylation substrates, JNK1 and IKKb. Inhibition of JNK1 by NO reduces Bcl-2 phosphorylation and increases the Bcl-2-Beclin 1 interaction, thereby disrupting hVps34/ Beclin 1 complex formation. Additionally, NO inhibits IKKb and reduces AMPK phosphorylation, leading to mTORC1 activation via TSC2. Overexpression of nNOS, iNOS, or eNOS impairs autophagosome formation primarily via the JNK1-Bcl-2 pathway. Conversely, NOS inhibition enhances the clearance of autophagic substrates and reduces neurodegeneration in models of Huntington's disease. Our data suggest that nitrosative stress-mediated protein aggregation in neurodegenerative diseases may be, in part, due to autophagy inhibition.
INTRODUCTION
Macroautophagy (henceforth referred to as "autophagy") is an intracellular bulk degradation process involved in the clearance of long-lived proteins and organelles, which affects various physiological and pathological processes, including develop-
ment, immunity, longevity, cancer, and neurodegenerative diseases (Mizushima et al., 2008). Autophagy initiates with the formation of isolation membranes called phagophores, which elongate and engulf a portion of the cytoplasm to form mature autophagosomes. Autophagosomes fuse with lysosomes to form autolysosomes, in which acidic lysosomal hydrolases degrade the engulfed contents. Autophagy is a highly conserved process; genetic analyses in yeast have identified several ATG (AuTophaGy related) genes, many of which have mammalian orthologs. The only known mammalian protein that specifically associates with autophagosome membranes throughout their lifespan is microtubule-associated protein 1 (MAPI) light chain 3 (LC3), the mammalian ortholog of yeast Atg8. LC3 normally exists in the cytosol as LC3-I. Upon autophagy induction, LC3-I conjugates with phosphatidylethanolamine to form the au-tophagosome-associated LC3-II. LC3-II levels (relative to actin/ tubulin loading controls) correlate with autophagosome numbers (Kabeya et al., 2000).
The classical pathway regulating mammalian autophagy involves the serine/threonine kinase, mammalian target of rapa-mycin (mTOR) (Rubinsztein et al., 2007). This protein negatively regulates autophagy via the mTOR complex 1 (mTORCI), which consists of raptor, GpL, and PRAS40 (Guertin and Sabatini, 2009). The activity of mTORCI can be inhibited by rapamycin or starvation, which are well-established inducers of autophagy (Noda and Ohsumi, 1998). Many diverse signals, such as growth factors, amino acids, and energy status, regulate autophagy by the mTORCI pathway (Meijer and Codogno, 2006). Recent studies have shown that mTORCI regulates autophagy by acting on a complex comprising mammalian Atg13, ULK1, and FIP200 (Mizushima, 2010).
Starvation also regulates autophagy by activating c-Jun N-terminal kinase 1 (JNK1), which in turn phosphorylates Bcl-2 at multiple sites (T69, S70, and S87). Bcl-2 normally inhibits autophagy by interacting with the autophagy protein Beclin 1,
High exp.
Low exp.
# # # <f -ÜT"
& ^V^ o
J* # <r <r
On Baf
100 80 60 40 20 0
Rat primary cortical neurons _ *** 100 -80 -60 -40 -20 -
100 80 60 40 20 0
HeLa cells -
I- LC3-I H LC3-II H LC3-I LC3-II
i-Actin
sosyo 40 toly 20 tuA 0
150 125 100 75 50 25 0
mRFP-GFP-LC3 HeLa cells
mRFP-GFP-LC3 HeLa cells
GFP-LC3 mRFP-LC3 Merge/DAPI £ olr nt GFP-LC3 mRFP-LC3 Merge/DAPI 0
20 ^m o C 20 ^m : / /V
a e DETA NONOate m>m
Full medium (FM)
Hanks' Balanced Salt Solution (HBSS)
F MAtg5*'* MEFs \3Atg5-'-
£ £ 30 S c 25 £ -S 25
Q_ TO 15 " 10 5
oOOOOOOQOOOOOO
C0nc (n M) £000000 £000000
(5 o> E
Control
DETA NONOate
# <£>
o -, 40
■è S 35
8 « 30 o es 25
-p ture2205 ® 'S 15
raS 10 At st 5
Figure 1. NO Inhibits Autophagosome Synthesis
(A) Immunoblot analysis with anti-LC3 antibody shows that NO donors reduced LC3-II levels in rat primary cortical neurons and decreased autophagosome synthesis in bafilomycin Ai-treated rat primary cortical neurons and HeLa cells.
whereas Bcl-2 phosphorylation inhibits this interaction to stimulate autophagy (Pattingre et al., 2005; Wei et al., 2008). Beclin 1 is a part of the class III phosphatidylinositol 3-kinase (PI3K)/hVps34 complex, and its binding with hVps34 is essential for the initiation of autophagosome formation (Pattingre et al., 2008).
Autophagy can also be regulated independently of mTOR (Sarkar et al., 2009b). Recent work has shown IKK (kB kinase) to be an important regulator of autophagy induction via multiple stimuli. IKK regulates autophagy independently of its effects on NFkB and acts both by enhancing AMPK phosphorylation-dependent mTOR inhibition and JNK1-mediated Bcl-2 phosphorylation (Criollo et al., 2010).
Reactive oxygen species (ROS) also regulate autophagy under amino acid and serum starvation conditions, where superoxide has been suggested to be the major ROS species involved in ROS-mediated autophagy (Chen et al., 2009; Scherz-Shouval et al., 2007). However, the specific roles of reactive nitrogen species, such as nitric oxide (NO), in autophagy have been unclear. NO is a ubiquitous cellular messenger molecule in the cardiovascular, nervous, and immune systems, where NO is capable of eliciting a multitude of physiological responses, such as blood flow regulation and tissue responses to hypoxia (Foster et al., 2009). Endogenous NO is synthesized from L-argi-nine by a family of NO synthases (NOS) in a two-step oxidation process. NO-based protein modification by S-nitrosylation, which is the redox-based modification of Cys thiol side chains, is a common mechanism of NO-mediated signal transduction (Hess et al., 2005). Protein S-nitrosylation not only plays vital physiological roles that are important in cellular homeostasis, but also can also contribute to a broad spectrum of human diseases, such as heart failure and neurodegeneration (Foster et al., 2009). An excess of NO resulting in nitrosative stress is believed to play a causal role in neuronal cell death in the context of neurodegenerative diseases (Gu et al., 2010).
Here we show that NO inhibits autophagic flux in mammalian cells. NO S-nitrosylates JNK1 and IKKß, and our data suggest that these events affect autophagy, as NO decreases JNK1 activity and Bcl-2 phosphorylation and activates mTORC1 in an IKKß- and TSC2-dependent manner. Overexpression of NOS isoforms also impairs autophagic flux. Conversely, inhibition of NO synthesis induces autophagy and protects against neurodegeneration in models of Huntington's disease (HD). Our data delineate the role of NO in regulating autophagy, which may have underlying implications in its myriad of cellular functions.
RESULTS
NO Inhibits Autophagosome Synthesis
We tested whether NO regulates autophagy using a number of NO-releasing chemical compounds (Keefer et al., 1996), such
as DEA NONOate, DETA NONOate, and SIN-1. These NO donors decreased endogenous LC3-II levels in rat primary cortical neurons and HeLa cells, suggesting that NO may be inhibiting autophagy (Figure 1A; see Figure S1Aavailable online). Because the steady state levels of LC3-II are affected both by synthesis and degradation, effects on autophagy are best assessed by clamping LC3-II/autophagosome degradation with bafilomycin A1 (see Experimental Procedures). This is a well-established method for monitoring autophagosome synthesis (Rubinsztein et al., 2009; Sarkar et al., 2007, 2009c). NO donors also reduced LC3-II levels in bafilomycin A1-treated rat primary cortical neurons or HeLa cells, compared to bafilomycin A1 treatment alone (control) (Figure 1A), indicating that NO impaired autophagosome synthesis.
We next analyzed autophagic flux in a stable HeLa cell line expressing mRFP-GFP-LC3 reporter, in which autophagosomes have both mRFP and GFP signals, whereas the autolysosomes emit only mRFP signal because of quenching of the GFP in the acidic lysosomal environment (Kimura et al., 2007; Sarkar et al., 2009a). NO donors decreased the number of autolysosomes in mRFP-GFP-LC3 HeLa cells cultured in full medium (FM) or when starved with Hank's buffered salt solution (HBSS), compared with untreated (control) cells (Figures 1B-1E), suggesting that NO inhibited autophagic flux under basal and starvation conditions.
To further verify our data on autophagic flux, we assessed the accumulation of EGFP-tagged mutant huntingtin (EGFP-HDQ74), a well-established autophagy substrate, where the proportion of cells with aggregates formed by this protein correlates linearly with expression levels (Ravikumar et al., 2004). NO donors increased the percentage of cells with EGFP-HDQ74 aggregates in Atg5+/+ (autophagy-competent) MEFs, but not in Atg5~'~ (autophagy-deficient) MEFs, which is consistent with an effect on autophagy inhibition (Figure 1F and Figure S1B). Furthermore, NO donors decreased the number of endogenous starvation-induced Atg16-positive structures in HeLa cells (Figures 1G and 1H). Because Atg16 is located on the phagophores and is not found on the autophagosomes (Mizushima et al., 2003), these data suggest that NO impaired autophagosome formation at an early stage.
NO Inhibits Autophagy Independently of the cGMP Pathway
A major signaling pathway mediating the effects of NO is the activation of guanylate cyclase leading to the formation of cyclic guanosine-3'5'-monophosphate (cGMP), which, in turn, activates cGMP-dependent protein kinase G (PKG) (Denninger and Marletta, 1999). To test whether cGMP regulates autophagy, we used 8-pCPT-cGMP, a cell-permeable analog of cGMP and aselective PKG activator (Geigeretal., 1992). HeLa cells treated
(B-E) Confocal microscopy images and analysis of autophagic flux by automated Cellomics microscopy show that NO donors reduced autolysosome numbers in mRFP-GFP-LC3 HeLa cells grown in full medium (FM) (B and D) or starved with HBSS (C and E). Cells in HBSS had more autolysosomes compared to FM (C). Autolysosome number in untreated cells in FM is set at 100%.
(F) NO donors increased EGFP-HDQ74 aggregates in a dose-dependent manner in EGFP-HDQ74-transfected Atg5+'+, but not in Atg5~'~, MEFs. Atg5~'~ MEFs had more EGFP-HDQ74 aggregates than Atg5+'+ MEFs.
(G and H) Confocal microscopy images (H) and immunofluorescence analysis with anti-Atg16 antibody (G) show that NO donors reduced the percentage of HeLa cells with Atg16-positive structures (arrows) under starvation. Graphical data denote mean ± SEM.
A DEA NONOate - + DETA NONOate - -
B DEA NONOate DETA NONOate
P-JNK H (T183/Y185) JNK1H
IP: JNK1 WB: P-JNK Input: WB: JNK1
■s 80
w © 6°
js^ ^ 40 ° 2° Pt
DEA NONOate DETA NONOate
+ -- +
D Empty Flag WT Myc-Bcl-2 Flag-Beclln 1 DEA NONOate DETA NONOate
WT Myc-Bcl-2 WT Myc-Bcl-2 Flag-Beclln 1
175 15° 125 1°° 75 5° 25
DEA NONOate - + DETA NONOate - -
° # ^ n is
' Flag-CA JNK1 - + DETA NONOate - -
DEA NONOate DETA NONOate
+ -- +
e 2°°
"o lat & 15°
ls le © 2- cl 1°°
e —1 cl -B B o 5°
P- °
Empty Flag + - -
AAA Myc-Bcl-2 + + +
Flag-Beclln 1 - + +
DEA NONOate - - +
DETA NONOate - - -
Flag-CA Jnk1 - + DETA NONOate - -
IP: Flag WB: Myc Input: WB: Myc Input: WB: Flag
AAA Myc-
Bcl-2 * AAA Myc-Bcl-2 Flag-.,. Beclln 1
IP: Flag WB: Myc Input: WB: Myc Input: WB: Flag
o ) 12°
PI e & 1°°
"o > atl OJ cl 8°
ls le £ B 6°
> e -2 ut 4°
cl B p ln 2° °
DEA NONOate -DETA NONOate -
Empty Flag hVps34 Flag-Beclln 1 DEA NONOate DETA NONOate
hVps34
hVps34
Flag-Beclln 1
IP: Flag WB: hVps34 Input:
WB: hVps34 Input: WB: Flag
G Empty Flag hVps34 Flag-Beclln 1 pcDNA3.1 AAA Myc-Bcl-2 DETA NONOate
1°° 8° 6° 4°
2° °
DEA NONOate DETA NONOate
o ^ <&
e 3s —1 CP
- + -- - +
hVps34
hVps34
Flag-Beclln 1 AAA Myc-Bcl- 2
— - IH' 11 1
1°° 8° 6°
P ^4° 2°
AAA Myc-Bcl-2 - + DETA NONOate - -
1°° 8° 6° 4°
2° °
- - + - + -
IP: Flag WB: hVps34 Input:
WB: hVps34 Input: WB: Flag Input: WB: Myc
Figure 2. NO Reduced Phosphorylation of JNK1 and Bcl-2, Leading to Increased Bcl-2-Beclin 1 and Decreased Beclin 1-hVps34 Interactions
(A) NO donors reduced JNK1 phosphorylation In HeLa cells, as analyzed by Immunopreclpltatlon with antl-JNK1 agarose-conjugated beads and Immunoblottlng with antl-phospho-JNK antlbody.
(B) NO donors reduced Bcl-2 phosphorylatlon ln HeLa cells, as analyzed by lmmunoblottlng wlth antl-phospho-Bcl-2 antlbody.
(C) Immunoblot analysls wlth antl-phospho-Bcl-2 antlbody shows that DETA NONOate could not reduce phospho-Bcl-2 ln Flag-CA JNK1 -transfected HeLa cells, where phospho-Bcl-2 was hlgher compared to mock-transfected cells.
(D and E) Immunopreclpltatlon wlth antl-Flag M2 affinlty agarose gel and lmmunoblottlng wlth antl-Myc antlbody shows that NO donors lncreased the lnteractlon of Flag-Beclln 1 wlth WT Myc-Bcl-2 (D), but not wlth AAA Myc-Bcl-2 (E), ln HeLa cells transfected wlth WT Myc-Bcl-2 (D) or AAA Myc-Bcl-2 (E) along wlth elther empty Flag or Flag-Beclin 1. Asterlsk denotes IgG band (E).
wlth 8-pCPT-cGMP had no effects on LC3-II levels or autopha-gosome synthesls (Flgure S1C). Likewise, 8-pCPT-cGMP had no effects on autolysosome numbers ln mRFP-GFP-LC3 HeLa cells, or on the accumulatlon of EGFP-HDQ74 (Flgures S1D and S1E), indicating that cGMP did not affect autophagy. Although 8-pCPT-cGMP had no effects on autophaglc flux, DETA NONOate reduced LC3-II levels ln the presence or absence of 8-pCPT-cGMP to a slmllar extent ln bafilomycln A1-treated HeLa cells, suggestlng that NO-medlated autophagy lnhlbltlon was independent of the cGMP pathway (Flgure S1F).
NO Increases Bcl-2-Beclin 1 Association by Inhibiting JNK1-Mediated Bcl-2 Phosphorylation
Activation of JNK1, but not JNK2, has been recently shown to medlate starvatlon-lnduced autophagy ln mammallan cells by phosphorylating Bcl-2 (Wel et al., 2008). NO donors can inhibit JNK1 vla S-nitrosylation at C116, leadlng to reduced JNK1 phosphorylation (Hess et al., 2005; Park et al., 2000). Furthermore, JNK1 lnhlbltlon lmpalrs both starvatlon-lnduced and basal au-tophagy (Wel et al., 2008). To test the possibility that NO-medlated autophagy lnhlbltlon may be actlng vla JNK1 inactivation, we confirmed that NO donors S-nltrosylated JNK1 and reduced endogenous JNK1 phosphorylatlon ln HeLa cells (Flgure 2A and Flgure S2A). NO donors also decreased endogenous Bcl-2 phosphorylatlon ln HeLa cells and human cortlcal neurons (Flgure 2B and Flgure S2B), but not ln cells expresslng constitutively active JNK1 (Flgure 2C). These data suggest that NO reduced Bcl-2 phosphorylatlon by JNK1 lnhlbltlon.
Because starvatlon induces autophagy by increasing Bcl-2 phosphorylatlon and consequently dlsruptlng the autophagy-lnhlbltory association of Bcl-2 and Beclln 1 (Pattlngre et al.,
2005), we next tested whether NO influences thls interaction by reduclng phospho-Bcl-2. HeLa cells expresslng Flag-tagged Beclln 1 (Flag-Beclln 1) and Myc-tagged Bcl-2 (Myc-Bcl-2) showed increased blndlng of Bcl-2 to Beclln 1 upon treatment wlth NO donors, suggestlng that the autophagy inhibitory effects of NO were due to lncreased assoclatlon of the antl-autophagy proteln Bcl-2 wlth Beclln 1 (Flgure 2D). However, the effect of NO donors on Bcl-2-Beclin 1 lnteractlon was abollshed ln cells expresslng Flag-Beclln 1 and nonphosphorylatable Myc-Bcl-2 (AAA Myc-Bcl-2) wlth mutatlons at the T69A, S70A and S87A phosphorylatlon sltes (Wel et al., 2008) (Flgure 2E), suggestlng that NO-medlated lncreased Bcl-2-Beclin 1 assoclatlon was due to lnhlbltlon of JNK1-dependent Bcl-2 phosphorylatlon.
Bcl-2 can also be S-nltrosylated by NO ln response to apoptotic stimuli at C158 and C229, wlth C229 belng the major site as its mutation abrogated Bcl-2 S-nltrosylatlon (Azad et al.,
2006). Uslng a mutant Bcl-2 construct that cannot be S-nltrosylated (C229A Bcl-2) (Azad et al., 2006), we found that NO donors not only lncreased Bcl-2-Beclin 1 assoclatlon ln Flag-Beclln 1 and Bcl-2 expresslng cells, but also ln Flag-Beclln 1 and C229A Bcl-2 expresslng cells (Flgures S2C and S2D). Therefore,
the effect of NO ln lncreaslng Bcl-2-Beclin 1 lnteractlon was lndependent of Bcl-2 S-nltrosylatlon on C229.
NO Impairs the Formation of Beclin 1/hVps34 Autophagy Initiation Complex
Beclln 1 regulates the lnltlatlon of autophagosome formatlon as a part of the hVps34/PI3K complex (Pattlngre et al., 2008). Conslstent wlth NO-medlated increase ln Bcl-2-Beclin 1 assoclatlon, NO donors reduced Beclin 1-hVps34 interaction in cells expressing Flag-Beclin 1 and hVps34, suggesting that NO disrupted Beclin 1/hVps34 complex formation that is essential for autophagy initiation (Figure 2F). Furthermore, lowered Bcl-2 phosphorylation influenced Beclin 1-hVps34 association, because cells expressing Flag-Beclin 1 and hVps34 had reduced lnteractlon ln the presence of AAA Myc-Bcl-2, lndlcatlng that dephosphorylatlon of Bcl-2 ls assoclated wlth an lmpalrment of Beclin 1/hVps34 complex formation (Figure 2G). Moreover, AAA Myc-Bcl-2 reduced Beclin 1-hVps34 interaction to a similar extent in the presence or absence of DETA NONOate (Figure 2G). Collectively, these data implicate that NO-mediated Bcl-2 dephosphorylation sequestered Beclin 1 from the Beclin 1/ hVps34 autophagy initiation complex into the Bcl-2/Beclin 1 au-tophagy lnhlbltory complex.
NO Inhibits Autophagy by Additional Mechanisms Apart from the JNK1-Bcl-2-Beclin 1 Pathway
In order to test whether NO-medlated autophagy lnhlbltlon was acting solely via the JNK1-Bcl-2-Beclin 1 pathway, we used MEFs stably expressing human wild-type Bcl-2 (WT Bcl-2) or AAA mutant Bcl-2 (AAA Bcl-2) (Wei et al., 2008). Interestingly, DETA NONOate inhibited autophagosome synthesis in both bafilomycinA-i -treated WT Bcl-2 and AAA Bcl-2 MEFs (Figure3A). NO donors also reduced EGFP-LC3 vesicles and increased EGFP-HDQ74 aggregation in both the cell lines (Figures 3B-3D).
We further studied the effects of NO in MEFs with targeted disruption of jnk1 or jnk2 genes (Tournier et al., 2000) (Figure S3A). Consistent with the effects of NO in AAA Bcl-2 MEFs, DETA NONOate inhibited autophagosome synthesis in bafilomycin AHreated WTJnk, Jnk1~'-, or Jnk2~'- MEFs (Figure 3E). These data indicate that NO impaired autophagy by additional mechanism(s) apart from modulating the JNK1-Bcl-2-Beclin 1 pathway.
NO Activates mTORC1 to Negatively Regulate Autophagy
We next investigated the effects of NO on the classical mTOR pathway. The activity of mTORC1, a protein kinase, can be assessed by the phosphorylation status of its substrate, ribosomal S6 kinase 1 (S6K), at T389, and that of the ribosomal S6 protein (S6), a substrate of S6K, at S235/236 (Martin and Hall, 2005). NO donors increased the phosphorylation of S6K and S6 in HeLa cells, suggesting activation of mTORC1 (Figures 3F and 3G).
(F) Immunoprecipitation with anti-Flag M2 affinity agarose gel and immunoblotting with anti-Vps34 antibody shows that NO donors decreased Flag-Beclin 1-hVps34 interaction in HeLa cells transfected with hVps34 along with either empty Flag or Flag-Beclin 1.
(G) Immunoprecipitation with anti-Flag M2 affinity agarose gel and immunoblotting with anti-Vps34 antibody shows that AAA Myc-Bcl-2 decreased Flag-Beclin 1-hVps34 interaction in the presence (right panel) or absence (left panel) of DETA NONOate in HeLa cells transfected with hVps34 along with either empty Flag or Flag-Beclin 1, and with pcDNA3.1 or AAA Myc-Bcl-2. Graphical data denote mean ± SEM.
DETA NONOate LC3-I LC3-II
High exp.
Low exp.
LC3-I LC3-II
Actin h
AAA Bcl-2 -
DETA NONOate
B DETA
Control NONOate
WT Bcl-2 MEFs AAA Bcl-2 MEFs
Control NONOate
co 5% 60
0_ JE 40 " 30 -hi g> 2° -10 -
DEA NONOate -DETA NONOate -
*** 40
■¡I 30
14 12 10
i? 6 F re 4 C3 co 4 HI eg 2
10 0 DEA NONOate DETA NONOate
WT Bcl-2 MEFs AAA Bcl-2 MEFs 16 14 12 10
+ -- +
P-S6 (S235/236)
DETA NONOate LC3-I
High exp.
Low exp.
LC3-II LC3-I LC3-II
Actin -
Baf + + DETA NONOate - +
100 80 60 40 20 0
DEA NONOate - + -DETA NONOate - - +
P-S6K H (T389) S6KH
P-S6 (S235/236) S6
* ä a
to á ~ 300
^ " 200
ri 0) 'S 250
IP-S6K □ P-S6
le P la
200 150 100 ^If 00 - 0 DEA NONOate DETA NONOate
■*■** *** JD
P-S6K (T389) S6K
P-S6 (S235/236) S6
s?!s 400
^ 2 2 300 of 6 or
e P lta ä o 100 Lao - 0 DEA NONOate -DETA NONOate -
- WT Bcl-2—I P-S6K □ P-S6
- + -- - + - + -- - +
-— - - - — —-
* I* * ****
— AAA Bcl-2—I IP-S6K □ P-S6
P-mTOR (S2448) LAMP1 Merge/DAPI ^
•Äs"
20jm 1mb£ -
% "V 0
Figure 3. NO Impairs Autophagy in AAA Bcl-2 and Jnk1-/- MEFs by Activating mTORCI
(A) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A^treated WT Bcl-2 and AAA Bcl-2 MEFs.
(B and C) NO donors decreased EGFP-LC3 vesicles in EGFP-LC3-transfected WT Bcl-2 and AAA Bcl-2 MEFs (C). Images were acquired by a confocal microscope (B). WT Bcl-2 and AAA Bcl-2 MEFs were analyzed separately.
(D) NO donors increased EGFP-HDQ74 aggregates in EGFP-HDQ74-transfected WT Bcl-2 and AAA Bcl-2 MEFs. WT Bcl-2 and AAA Bcl-2 MEFs were analyzed separately.
(E) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A^treated WTJnk, Jnk1-'-, and Jnk2-'- MEFs.
(F) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORCI in HeLa cells.
Similar effects of NO were found in WT Bcl-2 and AAA Bcl-2 MEFs (Figure 3H). An elevated mTORCI activity in AAA Bcl-2 MEFs may account for NO inhibiting autophagy in these cells. DETA NONOate also activated mTORCI in primary mouse and human cortical neurons, as well as in starved HeLa cells (Figures S3B and S3C), which are compatible with NO inhibiting neuronal and starvation-induced autophagy, respectively.
The regulation of mTORCI activity by amino acids has been correlated with the localization of mTORCI on late endo-somes/lysosomes via the Rag GTPases (Sancak et al., 2008). Although DETA NONOate increased mTOR phosphorylation in HeLa cells, there was no overt redistribution of mTOR or phos-pho-mTOR, which primarily colocalized with LAMPI-positive late endosomal/lysosomal compartments near the perinuclear region similar to the untreated cells (Figure 3I and Figure S3D).
Activation of mTORCI by NO Is Dependent on TSC2 and IKKß
The tuberous sclerosis complex (TSC1/2), consisting of a hetero-dimer of TSC1 and TSC2, is an upstream negative regulator of mTORCI. TSC1/2 is the GTPase-activating protein for the Ras-family GTP-binding protein Rheb, which directly binds and activates mTORCI (Guertin and Sabatini, 2009). Loss of TSC1 or TSC2 activity stimulates mTORC1 by enhancing Rheb activity (Figure S4A), which also impairs basal autophagy (Ravikumar et al., 2004; Williams et al., 2008; Zhou et al., 2009). Because the TSC1/2 complex regulates mTORC1 activity, we studied the effects of NO on mTORC1 in Tsc2+/+ and Tsc2-'- MEFs (Zhang et al., 2003). We found that NO donors increased the phosphorylation of S6K and S6 in Tsc2+/+, but not in Tsc2~'~, MEFs (Figure 4A), suggesting that NO-induced activation of mTORC1 was TSC2-dependent, by acting at, or above, TSC2.
NO S-nitrosylates and inhibits IKKß. However, the active IKK complex normally regulates autophagy by enhancing AMPK phosphorylation (possibly indirectly), which, in turn, inhibits mTOR via TSC1/2 (Criollo et al., 2010; Leeetal., 2007; Reynaert et al., 2004). To test whether NO activates mTOR by this pathway, we confirmed that NO donors S-nitrosylated IKKß and reduced its phosphorylation (Figure 4B and Figure S4B), leading to decreased AMPKa phosphorylation at the site phos-phorylated by IKK (Figure 4B and Figure S4C). Because NO decreases AMPK phosphorylation, we predicted that NO may enhance mTORC1 activity by this pathway (Inoki et al., 2003). Indeed, NO donors increased mTORC1 activity in Ikkß+/+, but not in Ikkß_/~, MEFs (Figure 4C). We also found increased mTORC1 activity in Ikkß-'~ MEFs, compared to Ikkß+/+ MEFs (Figure S4D). These data collectively indicate that NO-mediated mTORC1 activation is dependent on IKK and TSC2 activity.
NO Inhibits Autophagy by Two Independent Pathways
We further tested the effects of NO on autophagy in Tsc2+/+ and Tsc2~'~ MEFs, where DETA NONOate impaired autophago-
some synthesis in both the cell lines treated with bafilomycin A! (Figure 4D). Treatment with DETA NONOate or overexpression of AAA Myc-Bcl-2 also reduced EGFP-LC3 vesicle numbers in both Tsc2+/+ and Tsc2~'~ MEFs (Figure 4E). However, DETA NONOate could further reduce EGFP-LC3 vesicles in AAA Myc-Bcl-2 expressing Tsc2+/+ MEFs, but not in Tsc2~'~ MEFs, suggesting that the autophagy inhibition caused by NO was mediated predominantly (or maybe entirely) by the JNK1-Bcl-2 and mTORC1 pathways (Figure 4E).
Interestingly, AAA Myc-Bcl-2 expression decreased EGFP-LC3 vesicles even in Tsc2~'~ MEFs (Figure 4E). Moreover, we found no change in Bcl-2 phosphorylation in HeLa cells treated with or without the mTOR inhibitor rapamycin, or between Tsc2+/+ and Tsc2~'~ MEFs (Figures S4E and S4F). Furthermore, overexpression of constitutively active JNK1 had no effects on mTOR activity (Figure S4G), suggesting that the Bcl-2-Beclin 1 and mTORC1 pathways are independent of each other. These data implicate that NO impairs autophagy by two distinct mechanisms via the JNK1-Bcl-2-Beclin 1 and IKK-AMPK-TSC2-mTORC1 pathways.
Overexpression of NOS Isoforms Impairs Autophagosome Synthesis
Endogenous NO is generated by NOS, which has three mammalian isoforms arising from separate gene products: neuronal NOS (nNOS or NOS1), inducible NOS (iNOS or NOS2), and endothelial NOS (eNOS or NOS3). Although nNOS and eNOS are Ca2+-dependent enzymes producing NO, iNOS is a Ca2+-independent enzyme that produces NO when its expression is induced (Hess et al., 2005).
To test whether NOS overexpression recapitulated the effects of NO donors on autophagy, we used stable HEK293 cell lines expressing nNOS, iNOS-GFP, or eNOS (Figures S5A-S5E). Because of the absence of endogenous NOS isoforms in HEK293 (control) cells, the stable HEK293 NOS cell lines have elevated basal NO levels compared to the control cells (Kornberg et al., 2010; Liu et al., 1996; Pandit et al., 2009; Schmidt et al., 2001). We found that LC3-II levels and autophagosome synthesis were markedly reduced in all the NOS-expressing cell lines grown in the absence or presence of bafilomycin A1, compared to the control cells (Figures 5A-5D). Likewise, the NOS-expressing cells had reduced LC3-II levels and mCherry-LC3 vesicle numbers under starvation conditions, compared to the control cells; this effect was partly or wholly rescued by a broad-spectrum NOS inhibitor, Nu-nitro-L-arginine methyl ester hydrochloride (L-NAME) (Figures 5E and 5F and Figures S5F-S5J). Furthermore, the number of endogenous starvation-induced Atg16-positive structures was lower in all the NOS-expressing cells, compared to the control cells (Figures 5G and 5H). Therefore, overexpression of the NOS isoforms impairs basal and starvation-induced autophagy at an early stage of autophagosome synthesis.
(G) Confocal microscope images of immunofluorescence with anti-phospho-S6 antibody show that DETA NONOate increased S6 phosphorylation; arrowhead shows a cell where this effect was not observed.
(H) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORCI in WT Bcl-2 and AAA Bcl-2 MEFs.
(I) Confocal microscope images of immunofluorescence with anti-phospho-mTOR and anti-LAMPI antibodies in HeLa cells show that DETA NONOate increased phospho-mTOR but did not alter its distribution with lysosomes. Graphical data denote mean ± SEM.
A DEA NONOate - + -DETA NONOate - - +
P-S6K H (T389) S6KH
P-S6-"
(S235/236) S6
* S ^ œ £ ~ 200 W га <5
à- 2 a 150
m с- 100
ä "a о 50
"""S 0
DEA NONOate DETA NONOate
Tcs2+/+ ■ I P-S6K □ P-S6
• Tsc2-/--1
IP-S6K □ P-S6
ni ¿r 140 q ^ns^
t -- t
t -- t
B DEA NONOate -DETA NONOate -
: < ' Le P-
■ P-IKKa/ß □ P-AMPKa
100 -80 -60 -40 20 0
T * ***
DEA NONOate -DETA NONOate -
C DEA NONOate - + -DETA NONOate - - +
P-S6K (T389) S6K
P-S6 (S235/236) S6
6 it S ta
- Ikkß+'+ ■
IP-S6K □ P-S6
_ J S 200
о g 150 » <? a-
ä O. „ 100
ä с 2 50 0
DEA NONOate DETA NONOate
— Ikkß-'- -1
I P-S6K □ P-S6
NS NSNS
** 12^ M = NS NSNS
ЕЙМ
DETA NONOate LC3-I LC3-II ' LC3-I LC3-II
High exp.
Low exp.
Actin h
Baf t DETA NONOate -
E Tsc2+'+ MEFs Tsc2-'- MEFs
DETA NONOate - t - t - t - t
pcDNA3.1 AAA pcDNA3.1 AAA
Myc-Bcl-2 Myc-Bcl-2
Figure 4. Activation of mTORCI by NO Is Dependent on TSC2 and IKKß
(A) Immunoblot analyses with anti-phospho-S6K and antl-phospho-S6 antibodies show that NO donors activated mTORCI In Tsc2+/+ MEFs, but not in Tsc2~'~, MEFs.
(B) NO donors reduced phosphorylation of IKKa/ß and AMPKa in MEFs, as analyzed by immunoblotting with anti-phospho-IKKa/ß and anti-phospho-AMPKa antibodies, respectively.
(C) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORCI in Ikkß+/+ MEFs, but not in Ikkß~'~ MEFs.
(D) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A^treated Tsc2+/+ and Tsc2~'~ MEFs.
(E) DETA NONOate decreased EGFP-LC3 vesicles in Tsc2+/+ and Tsc2~'~ MEFs transfected with EGFP-LC3, along with either pcDNA3.1 or AAA Myc-Bcl-2. Although it further reduced EGFP-LC3 vesicles in Tsc2+/+ MEFs expressing AAA Myc-Bcl-2 compared to mock-transfected Tsc2+/+ MEFs, this effect was not seen in Tsc2~'~ MEFs. Tsc2+/+ and Tsc2~'~ MEFs were analyzed separately. Graphical data denote mean ± SEM.
High exp.
Low exp.
о <v о с* „& „<$>
^ ^ ^ - - + + Baf
/ /// -г
- - + + Baf
♦ LC3-I High
•*■ LC3-II exp.
♦ LC3-I Low
♦ LC3-II exp.
♦ Actin
■*■ nNOS
- - + + Baf
- LC3-I
- LC3-II
^ »Г & jT
♦ LC3-I High
♦ LC3-II exp.
♦ LC3-I Low
♦ LC3-II exp.
♦ Actin
♦ iNOS
■ HEK293 Control
□ HEK293 nNOS
□ HEK293 iNOS-GFP
□ HEK293 eNOS
- LC3-I -LC3-II
ь Actin eNOS
0 20 40 60 80 100 LC3-II levels relative to actin (%)
E HEK293
Control HEK293 nNOS HEK293 iNOS-GFP HEK293 eNOS
■ HEK293 Control "
□ HEK293 nNOS
□ HEK293 iNOS-GFP
□ HEK293 eNOS -
Untreated Untreated L-NAME Untreated L-NAME Untreated L-NAME
60 5G É1 Ф 40 aj о 30 -
O SS 20E > 10
L-NAME
HEK293 Control
HEK293 nNOS HEK293 iNOS-GFP
HEK293 eNOS
■ HEK293 Control
□ HEK293 nNOS
□ HEK293 iNOS-GFP
□ HEK293 eNOS
SG -, 70 -60 -50 -40 30 20 -10 G
Figure 5. Overexpression of Mammalian NOS Isoforms Inhibits Autophagosome Synthesis
(A-D) Immunoblot analyses with anti-LC3, along with anti-nNOS, anti-iNOS, and anti-eNOS antibodies, show decreased LC3-II levels in stable HEK293 cell lines overexpressing nNOS (A and D), iNOS-GFP (B and D), or eNOS (C and D) compared to HEK293 control cells in the presence or absence of bafilomycin Ai. (Eand F) mCherry-LC3 vesicles were reduced in mCherry-LC3-transfected stable HEK293 NOS cell lines compared to HEK293 control cells cultured in HBSS, an effect that was restored in the NOS cells by L-NAME (F). Images were acquired by a confocal microscope (E).
(G and H) Confocal microscopy images (G) and immunofluorescence analysis with anti-Atg16 antibody show that stable HEK293 NOS cell lines had fewer Atg16-positive structures under starvation, compared to HEK293 control cells (H). Graphical data denote mean ± SEM.
NOS Overexpression Inhibits the JNK1-Bcl-2 Pathway
We next tested the NO signaling pathways regulating autophagy in the HEK293 NOS stable cells under basal (FM) and starvation (HBSS) conditions. We found that the phosphorylation of JNK1 and Bcl-2 were reduced in all the NOS-expressing cells compared to the control cells cultured in FM or HBSS (Figures 6A-6F), compatible with the effects of NO donors. Surprisingly, the phosphorylation of S6K in FM or S6 in HBSS was also decreased in the NOS stable cells, which is in contrast to the NO donors that activated mTORCI (Figures 6A-6F). (Both phos-pho-S6K and phospho-S6 levels are reduced by starvation, although the levels of the latter are still sufficient to allow detection of a further decrease.) We speculate that these NOS cell lines may be chronically starved as a result of decreased autophagy, and this possibly inhibits the mTOR. Indeed, if one blocks autophagy for a prolonged period with a range of different chem-
ical inhibitors, one also sees an eventual decrease in mTORCI activity (Figure S6). Thus, autophagy is impaired in the NOS-expressing cells predominantly by inhibition of the JNK1-Bcl-2 pathway.
NOS Inhibitor L-NAME Induces Autophagy Independently of the Pathways Perturbed by NO
We next investigated whether NOS inhibition induces autophagy using the broad-spectrum NOS inhibitor, L-NAME. Consistent with the effects of NO donors on autophagy inhibition, L-NAME increased autophagosome synthesis (comparable to rapamycin) in bafilomycin A1-treated mouse primary cortical neurons and HeLa cells under basal conditions (Figure 7A and Figure S7A). It also had similar effects in rat primary cortical neurons under basal conditions and in HeLa cells under starvation conditions (Figures S7A and S7B). L-NAME also increased autophagic
X*- X*
nNOS P-JNK (T183/ Y185) JNK1
P-Bcl-2 (S70)
P-S6K (T389)
■ HEK293 Control □ HEK293 nNOS
FM Levels of phospho-protein relative to total protein (%)
& .сг>
P-JNK -----!
(T183/-»pHi»
Y185) v-1
JNK1-J
P-Bcl-2 (S70)
Bcl-2 h
P-S6K (T389)
0 20 40 60 80 100 Levels of phospho-protein relative to total protein (%)
чГ чГ
HEK293 Control HEK293 iNOS-GFP
eNOS P-JNK (T183/ Y185) JNK1
■ HEK293 Control □ HEK293 eNOS
P-S6K (T389)
]0 20 40 60 80 100 FM Levels of phospho-protein relative to total protein (%)
nNOS P-JNK (T183/ Y185) JNK1
HBSS Levels of phospho-protein relative to total protein (%)
0 20 40 60 80 100 Levels of phospho-protein relative to total protein (%)
J0 20 40 60 80 100 Levels of phospho-protein relative to total protein (%)
0 20 40
0 20 40
Figure 6. NOS Overexpression Primarily Inhibits the JNK1-Bcl-2 Pathway to Impair Autophagy
(A-F) Immunoblot analyses with anti-nNOS, anti-iNOS, anti-eNOS, anti-phospho-JNK1, antl-phospho-Bcl-2, anti-phospho-S6K, and antl-phospho-S6 antibodies show that stable HEK293 cell lines overexpressing nNOS (A and D), iNOS-GFP (B and E), or eNOS (C and F) inhibited both the JNK1-Bcl-2 and mTORC1 pathways compared to the HEK293 control cells under basal (FM) (A-C) or starvation (HBSS) (D-F) conditions. Graphical data denote mean ± SEM.
flux quantified as the number of autolysosomes using the mRFP-GFP-LC3 reporter (Figures 7B and 7C). The induction of autophagy by L-NAME was due to NOS inhibition because it had no effect on autophagy in HEK293 cells (lacking NOS isoforms) under basal or starvation condition (Figures S7C-S7E).
In contrast to the autophagy signaling pathways perturbed by NO donors, induction of autophagy by L-NAME was independent of mTORC1 activity or Bcl-2 phosphorylation, because HeLa cells treated with L-NAME exhibiting elevated LC3-II levels had no change in the phosphorylation of S6K, S6, or Bcl-2 (Figure S7F). Moreover, it had no effects on Beclin 1 or the lysosomal hydrolase, cathepsin D (Figure S7F).
NOS Inhibition Reduces Mutant Huntingtin Aggregation and Neurodegeneration in Models of Huntington's Disease
Autophagy is a critical pathway regulating the turnover of mutant huntingtin associated with HD (Ravikumar et al., 2004). Consistent with an effect on autophagy induction, L-NAME reduced the percentage of cells with EGFP-HDQ74 aggregates in au-tophagy-competent Atg5+/+ MEFs, but not in autophagy-defi-cient Atg5~'~ MEFs (Figure 7D). Likewise, siRNA knockdown
of nNOS also reduced the percentage of SK-N-SH human neuroblastoma cells with EGFP-HDQ74 aggregates (Figure S7G). L-NAME also enhanced the clearance of autophagy substrates (comparable to rapamycin) like EGFP-HDQ74 and A53T a-synu-clein in stable inducible PC12 cell lines (Sarkar et al., 2009c) (Figures S7H and S7I).
Because autophagy inducers have been shown to be protective in various animal models of HD and neurodegenerative disorders (Rubinsztein et al., 2007; Sarkar et al., 2009b), we tested the efficacy of L-NAME in a Drosophila model of HD. Flies expressing a mutant huntingtin fragment with 120 glutamines (Q120) in their photoreceptors exhibit retinal degeneration, a phenomenon that is not observed in flies expressing the wild-type protein with 23 glutamines (Q23) (Jackson et al., 1998). The photoreceptor degeneration observed in Q120 flies was significantly attenuated after treatment with L-NAME (Figure 7E). Moreover, the NOS gene in Drosophila is subjected to a complex transcriptional and posttranscriptional regulation (Stasiv et al., 2001). The product of one of its numerous transcripts, NOS4, acts as an endogenous dominant-negative regulator of NOS activity (Stasiv et al., 2004). Using this genetic approach to inhibit NOS activity, we showed
that NOS4 overexpression in the HD fly eye also significantly ameliorated Q120 toxicity (Figure 7F).
We further tested the therapeutic effects of L-NAME in a transgenic EGFP-HDQ71 zebrafish model of HD [Tg(rho:EGFP-HTT71Q)cu5] by assessing mutant huntingtin aggregates in the retina where the transgene is driven by the rhodopsin promoter (Williams et al., 200S). We found that L-NAME, as well as the au-tophagy inducer rapamycin, reduced the number of aggregates compared to the control, whereas autophagy inhibitors such as wortmannin and ammonium chloride (NH4Cl) increased aggregate count (Figures 7G and 7H and Figure S7J). The ability of L-NAME to reduce aggregates in HD zebrafish was abolished in the presence of NH4Cl, suggesting that its effect in vivo is autophagy dependent (Figure 7I).
DISCUSSION
Multiple Mechanisms Regulating NO-Mediated Autophagy Inhibition
Our study identifies a role of NO in the regulation of autophagy (Figure 7J). NO impaired autophagy at an early stage of autophagosome formation. The effects of NO in decreasing autophagic flux were robust in various cell lines and were independent of the cGMP pathway, which is an important mediator of NO effects. Our data suggest that NO inhibits autophagy by two distinct mechanisms (Figure 7J). First, NO S-nitrosylates and inactivates JNK1, thereby reducing Bcl-2 phosphorylation, which increases Bcl-2-Beclin 1 interaction and disrupts Beclin 1-hVps34 association. Second, NO activates mTORCI in a manner dependent on TSC2 and IKKß and is associated with decreased AMPK phosphorylation by IKK, consistent with the previously described inhibitory effects of NO on IKKß activity (Reynaert et al., 2004). Although NO inhibited autophagy in Jnk1~'~, AAA Bcl-2, and Tsc2 MEFs, its effects were abrogated in Tsc2~'~ MEFs expressing AAA Bcl-2. Thus, NO negatively regulates autophagy via the JNK1-Bcl-2-Beclin1 and the IKK-AMPK-TSC2-mTOR pathways. These two pathways implicated in starvation-induced au-tophagy appear to be independent of each other, because modulation of mTORC1 activity had no effects on Bcl-2 phosphorylation, and constitutively active JNK1 had no effects on mTORC1 activity.
Our data suggest that different ROS have divergent effects on autophagy. Although superoxides induced autophagy (Chen et al., 2009), NO impaired autophagosome synthesis. Overexpression of nNOS, iNOS, or eNOS also inhibited autophagic flux primarily via the JNK1-Bcl-2 pathway. Interestingly, the induction of autophagy by NOS inhibition was independent of the signaling pathways perturbed by NO or NOS overexpression, suggesting that there may be additional pathways regulating autophagy that are sensitive to changes in NO levels. Another possibility may be that NOS directly affects the autophagy machinery downstream of these signaling pathways.
A recent study reported that the plant extract evodiamine, which elicits apoptosis and autophagy, can also induce NO (Yang et al., 2008). There may be no contradiction between these findings and our observations, because it is possible that the effects of evodiamine on autophagy were independent of NO,
as this compound influences many other cellular processes and signaling cascades.
Consequences of NO Modulation in Neurodegenerative Diseases
Pharmacological or genetic inhibition of NOS increased the clearance of mutant huntingtin, which is an established autoph-agy substrate associated with HD (Ravikumaret al., 2004). Treatment with L-NAME, or expression of NOS4 in flies that acts as an endogenous dominant negative regulator of NOS activity (Stasiv et al., 2004), protected against neurodegeneration in a fly model of HD. Likewise, L-NAME reduced mutant huntingtin aggregates in a HD zebrafish model but was ineffective in the presence of the autophagy inhibitor NH4Cl. This is consistent with the protective effects seen with several autophagy inducers in various models of neurodegenerative diseases (Rubinsztein et al., 2007; Sarkar et al., 2009b).
Decreasing NO levels may protect against mutant huntingtin fragment toxicity via multiple mechanisms. For instance, excito-toxicity resulting from overstimulation of NMDA receptors is a prominent mechanism that has been implicated in neurodegenerative conditions such as Alzheimer disease, Parkinson's disease, and HD. Excessive NO production has been proposed as one of the mediators of excitotoxicity (Gu et al., 2010). Although this has previously been suggested to enhance protein misfolding by inactivation of protein disulphide isomerase, HSP90, and related mechanisms, our data suggest that the ensuing inhibition of autophagy will also contribute to this phenomenon because this will increase the levels of the aggregate-prone autophagy substrates. Various intracytosolic, mutant proteins associated with neurodegenerative diseases are primarily degraded by au-tophagy, and an impairment of autophagy in such conditions may augment their toxicity (Ravikumar et al., 2005; Rubinsztein et al., 2007; Sarkar et al., 2009b). Inactivation of autophagy will also enhance the susceptibility of such neurons to apoptotic insults (Boya et al., 2005; Ravikumar et al., 2006). However, our data provide an additional way whereby NO inhibition may mediate beneficial effects in neurodegenerative diseases where there is evidence of nitrosative stress-induced cell death linked to the pathogenesis of such diseases (Foster et al., 2009).
EXPERIMENTAL PROCEDURES
Complete methods can be found in Supplemental Experimental Procedures. Immunoblot Analysis
Cell lysates were subjected to western blot, as previously described (Sarkar et al., 2009c).
Autophagy Analysis
Analysis of Autophagosome Synthesis by LC3-II Levels
Autophagosome synthesis was analyzed by measuring LC3-II (immunoblot-ting with anti-LC3 antibody) in the presence of bafilomycin A1, as previously described (Rubinsztein et al., 2009; Sarkar et al., 2009c). Analysis of Autophagic Flux by mRFP-GFP-LC3 with an Automated Cellomics Microscope
Autolysosomes were quantified with an automated Cellomics microscope, as previously described (Sarkar et al., 2009a).
Figure 7. L-NAME Induces Autophagy and Reduces Mutant Huntingtin Aggregation/Neurodegeneration in Models of Huntington's Disease
(A) Immunoblot analyses with anti-LC3 antibody show that rapamycin (8 hr) and L-NAME (24 hr) increased autophagosome synthesis in bafilomycin A1-treated mouse primary cortical neurons and HeLa cells.
(B and C) Confocal microscopy images (B) and analysis of autophagic flux by automated Cellomlcs microscope (C) show that L-NAME increased autolysosomes in mRFP-GFP-LC3 HeLa cells.
(D) L-NAME reduced EGFP-HDQ74 aggregates in EGFP-HDQ74-transfected Atg5+'+, but not in Atg5MEFs.
(E) Drosophila expressing mutant huntingtin exon 1 (Q120) shows a significant decrease in neurodegeneratlon (p < 0.001, paired t test) upon L-NAME treatment compared to DMSO.
(F) Expression of an endogenous negative regulator of NOS activity (NOS4) significantly attenuates neurodegeneratlon (p < 0.05, paired t test) in Drosophila expressing mutant huntingtin exon 1 (Q120).
Analysis of Autophagosome Numbers by EGFP-LC3 or mCherry-LC3 Vesicles
The percentage of EGFP- or mCherry-positive cells with >5 EGFP-LC3 or mCherry-LC3 vesicles was assessed with a fluorescence microscope, as previously described (Sarkar et al., 2007).
Statistical Analyses
Statistical analyses were performed using STATVIEW v4.53 and SPSS 9, as previously described (Sarkar et al., 2009c). Statistical data in figures are detailed in Supplemental Notes (***, p < 0.001; **, p < 0.01; *, p < 0.05; NS, nonsignificant).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, Supplemental Experimental Procedures, Supplemental References, and Supplemental Notes and can be found with this article online at doi:10.1016/j.molcel.2011.04.029.
ACKNOWLEDGMENTS
WethankT. Yoshimori, N. Mizushima, B. Levine, R.J. Davis, D.J. Kwiatkowski, A.R. Tee, M. Karin, S.H. Snyder, K. Schmidt, W.C. Sessa, N.T. Eissa, Y. Rojanasakul, R. Tsien, G.R. Jackson, G. Enikolopov, W. Greene, the laboratory of the late S.J. Korsmeyer, Developmental Studies Hybridoma Bank, and Addgene for valuable reagents and P. Tyers, A. Casez, M. Quick, A. McNabb, T. Dyl, R. Antrobus, T. DiCesare, S. Gupta, and G. Sahay for technical support. We are grateful for Hughes Hall Research Fellowship (support to S.S. and V.I.K.), NIHR Biomedical Research Centre at Addenbrooke's Hospital and MRC Skills Gap Award (support to A.F.), Action Medical Research Training Fellowship (support to B.R.U.), Ligue Nationale contre le Cancer, Agence Nationale pour la Recherche, AXA Chair for Longevity Research (support to G.K.), Wellcome Trust Senior Fellowship in Clinical Science (support to D.C.R.), Medical Research Council, Sackler Trust, and National Institute for Health Research Biomedical Research Centre at Adden-brooke's Hospital for funding.
Received: May 11, 2010 Revised: December 8, 2010 Accepted: April 27, 2011 Published: July 7, 2011
REFERENCES
Azad, N., Vallyathan, V., Wang, L., Tantishaiyakul, V., Stehlik, C., Leonard, S.S., and Rojanasakul, Y. (2006). S-nitrosylation of Bcl-2 inhibits its ubiqui-tin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J. Biol. Chem. 281, 34124-34134.
Boya, P., Gonzalez-Polo, R.A., Casares, N., Perfettini, J.L., Dessen, P., Larochette, N., Metivier, D., Meley, D., Souquere, S., Yoshimori, T., et al. (2005). Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25, 1025-1040.
Chen, Y., Azad, M.B., and Gibson, S.B. (2009). Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ. 16, 1040-1052. Criollo, A., Senovilla, L., Authier, H., Maiuri, M.C., Morselli, E., Vitale, I., Kepp, O., Tasdemir, E., Galluzzi, L., Shen, S., et al. (2010). The IKK complex contributes to the induction of autophagy. EMBO J. 29, 619-631.
Denninger, J.W., and Marletta, M.A. (1999). Guanylate cyclase and the NO/ cGMP signaling pathway. Biochim. Biophys. Acta 1411, 334-350.
Foster, M.W., Hess, D.T., and Stamler, J.S. (2009). Protein S-nitrosylation in health and disease: a current perspective. Trends Mol. Med. 15, 391-404.
Geiger, J., Nolte, C., Butt, E., Sage, S.O., and Walter, U. (1992). Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc. Natl. Acad. Sci. USA 89, 1031-1035.
Gu, Z., Nakamura, T., and Lipton, S.A. (2010). Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol. Neurobiol. 41, 55-72. Guertin, D.A., and Sabatini, D.M. (2009). The pharmacology of mTOR inhibition. Sci. Signal. 2, pe24.
Hess, D.T., Matsumoto, A., Kim, S.O., Marshall, H.E., and Stamler, J.S. (2005). Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. б, 150-166.
Inoki, K., Zhu, T., and Guan, K.L. (2003). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590.
Jackson, G.R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P.W., MacDonald, M.E., and Zipursky, S.L. (199S). Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633-642.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., and Yoshimori, T. (2000). LC3, a mammalian homologue of yeast ApgSp, is localized in autophagosome membranes after processing. EMBO J. 19, 5720-572S.
Keefer, L.K., Nims, R.W., Davies, K.M., and Wink, D.A. (1996). "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268, 2S1-293.
Kimura, S., Noda, T., and Yoshimori, T. (2007). Dissection of the autophago-some maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452-460.
Kornberg, M.D., Sen, N., Hara, M.R., Juluri, K.R., Nguyen, J.V., Snowman, A.M., Law, L., Hester, L.D., and Snyder, S.H. (2010). GAPDH mediates nitrosy-lation of nuclear proteins. Nat. Cell Biol. 12, 1094-1100.
Lee, D.F., Kuo, H.P., Chen, C.T., Hsu, J.M., Chou, C.K., Wei, Y., Sun, H.L., Li, L.Y., Ping, B., Huang, W.C., et al. (2007). IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440-455.
Liu, J., Garcia-Cardena, G., and Sessa, W.C. (1996). Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35, 13277-132S1. Martin, D.E., and Hall, M.N. (2005). The expanding TOR signaling network. Curr. Opin. Cell Biol. 17, 15S-166.
Meijer, A.J., and Codogno, P. (2006). Signaling and autophagy regulation in health, aging and disease. Mol. Aspects Med. 27, 411-425.
Mizushima, N. (2010). The role of the Atg1/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol. 22, 132-139.
Mizushima, N., Kuma, A., Kobayashi, Y., Yamamoto, A., Matsubae, M., Takao, T., Natsume, T., Ohsumi, Y., and Yoshimori, T. (2003). Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J. Cell Sci. 116, 1679-16SS.
(G-I) Images from the retina of transgenic HD zebrafish show mutant huntingtin aggregates (arrows) (G). Treatment with rapamycin or L-NAME reduced the number of aggregates (H). L-NAME did not reduce aggregates in the presence of NH4Cl, which increased aggregate count (I).
(J) NO inhibits autophagy by S-nitrosylating and inhibiting JNK1 phosphorylation, thereby reducing phospho-Bcl-2 and increasing Bcl-2-Beclin 1 interaction, which disrupts hVps34-Beclin 1 association. NO also S-nitrosylates and inhibits IKKß phosphorylation, leading to reduced phospho-AMPK and TSC2 activity, which alleviates the inhibitory effect of TSC1/2 on Rheb (denoted by "x"), thereby allowing Rheb to activate mTORCI and inhibit autophagy. Overexpression of NOS isoforms impairs autophagy by inhibiting the JNK1 pathway, whereas NOS inhibition by L-NAME induces autophagy by mechanism distinct from the NO pathways. Graphical data denote mean ± SEM, except in (E) and (F).
Mizushima, N., Levlne, B., Cuervo, A.M., and Klionsky, D.J. (2008). Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075. Noda, T., and Ohsumi, Y. (1998). Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273, 3963-3966. Pandit, L., Kolodzlejska, K.E., Zeng, S., and Elssa, N.T. (2009). The physiologic aggresome mediates cellular inactivation of iNOS. Proc. Natl. Acad. Scl. USA 106, 1211-1215.
Park, H.S., Huh, S.H., Kim, M.S., Lee, S.H., and Choi, E.J. (2000). Nitric oxide negatively regulates c-Jun N-termlnal kinase/stress-activated protein kinase by means of S-nltrosylatlon. Proc. Natl. Acad. Scl. USA 97, 14382-14387.
Pattlngre, S., Espert, L., Biard-Piechaczyk, M., and Codogno, P. (2008). Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90, 313-323.
Pattlngre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M., Schneider, M.D., and Levine, B. (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939.
Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Easton, D.F., Duden, R., O'Kane, C.J., and Rubinsztein, D.C. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglut-amine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585-595.
Ravlkumar, B., Acevedo-Arozena, A., Imarisio, S., Berger, Z., Vacher, C., O'Kane, C.J., Brown, S.D., and Rubinsztein, D.C. (2005). Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 37, 771-776.
Ravikumar, B., Berger, Z., Vacher, C., O'Kane, C.J., and Rubinsztein, D.C. (2006). Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 15, 1209-1216.
Reynaert, N.L., Ckless, K., Korn, S.H., Vos, N., Guala, A.S., Wouters, E.F., van der Vliet, A., and Janssen-Heininger, Y.M. (2004). Nitric oxide represses inhibitory kappaB kinase through S-nltrosylatlon. Proc. Natl. Acad. Scl. USA 101, 8945-8950.
Rubinsztein, D.C., Cuervo, A.M., Ravikumar, B., Sarkar, S., Korolchuk, V., Kaushik, S., and Klionsky, D.J. (2009). In search of an "autophagomometer". Autophagy 5, 585-589.
Rubinsztein, D.C., Gestwicki, J.E., Murphy, L.O., and Klionsky, D.J. (2007). Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6, 304-312.
Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Bar-Peled, L., and Sabatini, D.M. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501. Sarkar, S., Perlstein, E.O., Imarisio, S., Pineau, S., Cordenler, A., Maglathlin, R.L., Webster, J.A., Lewis, T.A., O'Kane, C.J., Schrelber, S.L., and Rubinsztein, D.C. (2007). Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3, 331-338.
Sarkar, S., Korolchuk, V., Renna, M., Winslow, A., and Rubinsztein, D.C. (2009a). Methodological considerations for assessing autophagy modulators: a study with calcium phosphate precipitates. Autophagy 5, 307-313. Sarkar, S., Ravikumar, B., Floto, R.A., and Rubinsztein, D.C. (2009b). Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 16, 46-56.
Sarkar, S., Ravlkumar, B., and Rubinsztein, D.C. (2009c). Autophagic clearance of aggregate-prone proteins associated with neurodegeneration. Methods Enzymol. 453, 83-110.
Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., and Elazar, Z. (2007). Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26, 1749-1760. Schmidt, K., Andrew, P., Schrammel, A., Groschner, K., Schmltz, V., Kojda, G., and Mayer, B. (2001). Comparison of neuronal and endothelial isoforms of nitric oxide synthase in stably transfected HEK 293 cells. Am. J. Physiol. Heart Circ. Physiol. 281, H2053-H2061.
Stasiv, Y., Regulski, M., Kuzin, B., Tully, T., and Enikolopov, G. (2001). The Drosophila nitric-oxide synthase gene (dNOS) encodes a family of proteins that can modulate NOS activity by acting as dominant negative regulators. J. Biol. Chem. 276, 42241-42251.
Staslv, Y., Kuzin, B., Regulski, M., Tully, T., and Enlkolopov, G. (2004). Regulation of multlmers via truncated isoforms: a novel mechanism to control nitric-oxide signaling. Genes Dev. 18, 1812-1823.
Tournler, C., Hess, P., Yang, D.D., Xu, J., Turner, T.K., Nimnual, A., Bar-Sagi, D., Jones, S.N., Flavell, R.A., and Davis, R.J. (2000). Requirement of JNK for stress-induced activation of the cytochrome c-medlated death pathway. Science 288, 870-874.
Wei, Y., Pattlngre, S., Sinha, S., Basslk, M., and Levlne, B. (2008). JNK1-medi-ated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30, 678-688.
Williams, A., Sarkar, S., Cuddon, P., Ttofi, E.K., Saiki, S., Siddiqi, F.H., Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P., et al. (2008). Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4, 295-305.
Yang, J., Wu, L.J., Tashino, S., Onodera, S., and Ikejima, T. (2008). Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radlc. Res. 42, 492-504.
Zhang, H., Cicchetti, G., Onda, H., Koon, H.B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C.L., and Kwiatkowski, D.J. (2003). Loss of Tsc1/ Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulatlon of PDGFR. J. Clin. Invest. 112, 1223-1233.
Zhou, X., Ikenoue, T., Chen, X., Li, L., Inokl, K., and Guan, K.L. (2009). Rheb controls misfolded protein metabolism by inhibiting aggresome formation and autophagy. Proc. Natl. Acad. Scl. USA 106, 8923-8928.
